(Q39737347)

14 September 2017

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis (English)

1 reference

14 September 2017

0 references

0 references

1 reference

2

1 reference

Jan Willem Cohen Tervaert

14 September 2017

5

object named as

Jan Willem Cohen Tervaert

1 reference

14 September 2017

Stephanie Knippenberg

1

1 reference

14 September 2017

Mariëlle Thewissen

3

1 reference

14 September 2017

Evelyn Peelen

4

1 reference

14 September 2017

Raymond Hupperts

6

1 reference

14 September 2017

Jan Damoiseaux

7

1 reference

14 September 2017

20 June 2011

1 reference

Multiple Sclerosis Journal

14 September 2017

1 reference

14 September 2017

17

1 reference

14 September 2017

12

1 reference

14 September 2017

1418-1423

1 reference

Vitamin D and multiple sclerosis

14 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Vitamin D as an immune modulator in multiple sclerosis, a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Immunomodulatory effects of Vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

B cells as therapeutic targets in autoimmune neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

B cells and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Analysis of somatic mutation in five B cell subsets of human tonsil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Is the blood B-cell subset profile diagnostic for Sjogren syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Phenotypic and functional heterogeneity of human memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

The paradox of CD5-expressing B cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

The role of APRIL and BAFF in lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Memory and naïve B-cell subsets in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511412655

21 January 2018

Identifiers

DOI

10.1177/1352458511412655

1 reference

14 September 2017

1 reference